NEUROG3 Human

Neurogenin 3 Human Recombinant
Cat. No.
BT12172
Source
Escherichia Coli.
Synonyms
Neurogenin 3, Class A Basic Helix-Loop-Helix Protein 7, Protein Atonal Homolog 5, BHLHA7, Math4B, NGN3, Atoh5.
Appearance
Sterile Filtered clear solution.
Purity
Greater than 85% as determined by SDS-PAGE.
Usage
THE BioTeks products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

NEUROG3 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 234 amino acids (1-214) and having a molecular mass of 25.1 kDa. NEUROG3 is fused to a 20 amino acid His-tag at N-terminus.

Product Specs

Introduction
The transcription factor NEUROG3, classified as a basic helix-loop-helix (bHLH) protein, plays a crucial role in the development of neurons. It forms a heterodimer with another bHLH protein to exert its function. Genetic mutations affecting the NEUROG3 gene can lead to a condition known as congenital malabsorptive diarrhea 4 (DIAR4).
Description
Recombinant human NEUROG3, expressed in E. coli, is a single polypeptide chain that lacks glycosylation. It comprises 234 amino acids, with residues 1-214 forming the core protein. A 20 amino acid His-tag is fused to the N-terminus, resulting in a molecular weight of 25.1 kDa.
Physical Appearance
A clear solution that has been sterilized through filtration.
Formulation
The provided NEUROG3 solution has a concentration of 0.25mg/ml and is formulated in a buffer containing 20mM Tris-HCl (pH 8.0), 0.4M Urea, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), keep the solution refrigerated at 4°C. For extended storage, freeze the solution at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage to enhance stability. It is important to avoid repeated cycles of freezing and thawing.
Purity
Analysis by SDS-PAGE indicates a purity level exceeding 85%.
Synonyms
Neurogenin 3, Class A Basic Helix-Loop-Helix Protein 7, Protein Atonal Homolog 5, BHLHA7, Math4B, NGN3, Atoh5.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MTPQPSGAPT VQVTRETERS FPRASEDEVT CPTSAPPSPT RTRGNCAEAE EGGCRGAPRK LRARRGGRSR PKSELALSKQ RRSRRKKAND RERNRMHNLN SALDALRGVL PTFPDDAKLT KIETLRFAHN YIWALTQTLR IADHSLYALE PPAPHCGELG SPGGSPGDWG SLYSPVSQAG SLSPAASLEE RPGLLGATSS ACLSPGSLAF SDFL

Product Science Overview

Introduction

Neurogenin 3 (NGN3) is a basic helix-loop-helix (bHLH) transcription factor that plays a crucial role in the development of endocrine cells in the pancreas and intestine. It is also involved in the determination of neural precursor cells in the neuroectoderm. NGN3 is essential for the differentiation of endocrine progenitor cells into various hormone-producing cells, including insulin-producing β-cells. The recombinant form of Neurogenin 3 (Human Recombinant) is produced using advanced biotechnological methods to facilitate research and therapeutic applications.

Preparation Methods

The production of human recombinant Neurogenin 3 involves several steps to ensure high purity and biological activity. The gene encoding NGN3 is first codon-optimized to enhance protein expression in Escherichia coli (E. coli) strain BL21 (DE3). The codon-optimized NGN3 sequence is then fused in-frame to various fusion tags that facilitate cell penetration, nuclear translocation, and affinity purification .

The gene insert with the fusion tags is cloned into an expression vector, such as pET28a(+), for heterologous expression in E. coli cells. The expression conditions are optimized to produce a soluble form of the recombinant NGN3 fusion protein. The protein is then purified to homogeneity (purity >90%) under native conditions, retaining its secondary structure post-purification . This purified protein is tested for cytotoxicity and biological activity in human cells, ensuring its suitability for various biological applications .

Chemical Reactions Analysis

Neurogenin 3 undergoes complex regulation, including post-translational modifications such as ubiquitylation. The ubiquitin proteasome system (UPS) is responsible for the rapid turnover of NGN3, regulating its stability and transcriptional activity. NGN3 can be ubiquitylated on lysines, the N-terminus, and non-canonical residues such as cysteines and serines/threonines . This rapid turnover is influenced by binding to its heterodimeric partner E protein and the presence of cyclin-dependent kinase (cdk) inhibitors .

The stability and activity of NGN3 are critical for its role in the specification and differentiation of endocrine cells. The regulation of NGN3 by the UPS and other post-translational mechanisms ensures precise control over its function during development and cellular processes .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.